US equities
|
INTC
$119.13
▼-0.17%
MU
$1,074.89
▲+0.00%
NVDA
$233.95
▲+0.00%
SNDK
$1,719.99
▲+0.00%
SDEV
$7.48
▲+0.00%
SPCX
$158.96
▲+0.00%
AMD
$633.91
▲+0.00%
TSLA
$370.59
▲+0.00%
INTC
$119.13
▼-0.17%
MU
$1,074.89
▲+0.00%
NVDA
$233.95
▲+0.00%
SNDK
$1,719.99
▲+0.00%
SDEV
$7.48
▲+0.00%
SPCX
$158.96
▲+0.00%
AMD
$633.91
▲+0.00%
TSLA
$370.59
▲+0.00%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Oculis Holding AG - Ordinary shares
(NQ:
OCS
)
8.730
UNCHANGED
Delayed Quote
Updated: 4:00 PM EDT, Oct 2, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Oculis Holding AG - Ordinary shares
< Previous
1
2
3
4
Next >
Oculis Announces Pricing of $40.25 Million Public Offering of Ordinary Shares
May 31, 2023
From
Oculis SA
Via
GlobeNewswire
Intel, Noah Holdings, Twilio And Other Big Stocks Moving Higher On Wednesday
↗
May 31, 2023
U.S. stocks traded lower, with the Dow Jones dropping over 250 points on Wednesday. Here are some big stocks recording gains in today’s session. SunCar Technology Group Inc. (NASDAQ: SDA) shares gained...
Via
Benzinga
Oculis Announces Launch of Proposed Public Offering of Ordinary Shares
May 30, 2023
From
Oculis SA
Via
GlobeNewswire
Oculis to Participate and Present at Upcoming EuDES Meeting
May 24, 2023
From
Oculis SA
Via
GlobeNewswire
Oculis Announces Positive Top Line Results from DIAMOND Stage 1 Phase 3 Trial in Diabetic Macular Edema with OCS-01 Eye Drops
May 22, 2023
From
Oculis SA
Via
GlobeNewswire
Oculis Co-founders Selected as Finalists in European Inventor Award 2023
May 11, 2023
From
Oculis SA
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For April 28, 2023
↗
April 28, 2023
Via
Benzinga
Oculis Opens New Offices in the US and Expands its US Team by Appointing Dr. Fang Li as Senior Vice President, Regulatory Affairs
April 26, 2023
From
Oculis SA
Via
GlobeNewswire
Harley-Davidson, Sportsman's Warehouse And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
↗
April 13, 2023
U.S. stock futures traded higher this morning. Here are some big stocks recording losses in today’s pre-market trading session.
Via
Benzinga
Why GE HealthCare Technologies Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
↗
April 25, 2023
Gainers
Via
Benzinga
Oculis to Participate at Upcoming Investor Conferences
April 05, 2023
From
Oculis SA
Via
GlobeNewswire
Oculis to Host Conference Call on April 13, 2023 to Discuss Late-Stage Pipeline and Near-Term Clinical Milestones
April 04, 2023
From
Oculis SA
Via
GlobeNewswire
Stocks That Hit 52-Week Lows On Monday
↗
March 27, 2023
On Monday, 89 stocks made new 52-week lows.
Via
Benzinga
Oculis to Ring Nasdaq Stock Market Opening Bell in Celebration of its Successful Listing
March 22, 2023
From
Oculis SA
Via
GlobeNewswire
Oculis Completes Enrollment in Phase 3 OCS-01 OPTIMIZE Trial
March 16, 2023
From
Oculis SA
Via
GlobeNewswire
Why Aclaris Therapeutics Shares Are Trading Lower By Around 55%? Here Are Other Stocks Moving In Monday's Mid-Day Session
↗
March 06, 2023
Gainers Unicycive Therapeutics, Inc. (NASDAQ: UNCY) shares surged 159% to $1.27 after the company announced a private placement of up to $130 million in gross proceeds to commercialize and launch...
Via
Benzinga
< Previous
1
2
3
4
Next >
